FITC antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-FITC (FITC) antibodies (anti-FITC, anti-FITC) and diagnostic hapten-carrier conjugates BSA-FITC (FITC), OVA-FITC (FITC), KLH-FITC (FITC) antigens for Inflammation/autoimmune/inflammatory disease FITC detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Inflammation/autoimmune/inflammatory disease diagnostics products collection>>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-FITC

OVA-FITC

Anti-human FITC mouse monoclonal antibody (mAb)

Anti-human FITC human monoclonal antibody (mAb)

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. What is FITC, and what is its role in in vitro diagnosis (IVD)?

Answer: Fluorescein Isothiocyanate (FITC) is a synthetic compound known for its remarkable fluorescent properties. In the realm of in vitro diagnosis (IVD), FITC is a linchpin that contributes significantly to the precision and sensitivity of diagnostic assays. Its utilization as a fluorescent probe and labeling agent has revolutionized the field of biomedical diagnostics.

FITC operates as a fluorochrome by absorbing light at one wavelength and emitting light at a longer wavelength, resulting in a vivid and distinguishable fluorescence. This unique property makes FITC a pivotal component in various IVD applications. Its role primarily revolves around the development of highly specific and accurate diagnostic tests.

In practice, FITC is conjugated to antibodies, antigens, or other biomolecules to create labeled probes that can selectively bind to specific target molecules within patient samples. These labeled probes act as beacons, enabling the detection and quantification of a wide range of analytes, including proteins, nucleic acids, and cellular structures.

FITC is instrumental in various diagnostic techniques, such as enzyme-linked immunosorbent assays (ELISA), immunofluorescence assays, and flow cytometry. These tests are indispensable for diagnosing a myriad of medical conditions, including infectious diseases, autoimmune disorders, cancer, and more. FITC's presence in these assays ensures that they deliver precise and reliable results, crucial for clinical decision-making.

Beyond diagnostics, FITC plays a pivotal role in advancing research endeavors. It is a key component in fluorescence microscopy, a powerful tool that allows scientists to visualize and study cellular and molecular structures with exceptional detail. This capability is vital for understanding disease mechanisms, conducting drug discovery research, and unraveling complex biological processes.

2. Why measure FITC?

Answer: The measurement of FITC is essential in IVD for a multitude of compelling reasons, rooted in its unmatched performance and versatility.

First and foremost, FITC-enhanced assays offer an unparalleled level of sensitivity and specificity. This precision is indispensable for the detection of minute quantities of target analytes, ensuring that diagnostic tests can reliably identify the presence of biomarkers associated with specific diseases. The ability to detect low concentrations of analytes is critical for early disease diagnosis, allowing for timely intervention and improved patient outcomes.

FITC's reliability in delivering highly specific results makes it an ideal choice for the development of point-of-care testing (POCT) devices. These portable diagnostic tools provide rapid and accurate results at the patient's bedside or in remote settings, reducing the time to diagnosis and enabling prompt medical interventions. FITC's role in POCT is pivotal in improving healthcare access and ensuring that patients receive timely care.

Furthermore, FITC aids in the development of novel diagnostic methodologies, contributing to the ongoing evolution of IVD. Researchers and clinicians continually explore innovative ways to leverage FITC's fluorescent properties to create advanced diagnostic platforms with improved performance and expanded capabilities.

In summary, measuring FITC is not just a technical necessity; it is a driving force behind the advancement of IVD. Its unparalleled sensitivity, specificity, and versatility support the development of cutting-edge diagnostic tests, empower healthcare providers with reliable tools for disease diagnosis, and enable researchers to push the boundaries of medical science. FITC's presence in the biopharmaceutical industry underscores its pivotal role in delivering accurate and actionable diagnostic information, ultimately improving patient care and public health.

About GDU